European Companies Search Engine
Company statute Hrb5 Feb 2014 German Trade Register Announcements, Germany
Overview
Text
HRB 19747: Augenklinik Dardenne SE,
Unnamed street ??, 69126 Heidelberg, Germany
. The Annual General Meeting of November 28, 2013 approved the amendment of the Articles of Association in Section 20 (Annual Financial Statements). As the acquiring company, the company entered into a post-Foundation and transfer agreement with the following contractual partners on November 28, 2013: a) Dr. Hans Jakob Limbach, born on November 5, 201947, Heidelberg; b) Dr. Jan Bartel, born on June 18, 201958, Nußloch; c) Dr. Cyrill Müller, born September 17, 201968, Heidelberg; d) Dr. Christoph Marcus Niederau, born September 17, 201962, Wuppertal; e) Dr. Martin Holfelder, born On July 14, 201963,Mörlenbach; f) Prof. Dr. Guido Funke, born on May 8, 201966, Ermatingen (Switzerland) g) Dr. Diethard Müller, born on October 30, 201959, Weingarten; h) Dr. Martina Fliser, born on January 20, 201965, Heidelberg; i) Dr. Dr. Edgar Raude, born June 1, 201951, Ludwigsburg; j) Dr. Peter Schulz, born April 18, 201942, Ludwigsburg; k) Prof. Dr. Paul Cullen, born on June 17, 201960, Münster; l) Dr. Christian Haas, born on March 17, 201966, Freiburg; m) Dr. Elke Waltraud Müller, born on December 4, 201964, Karlsruhe; n) Dr. Martin Erich Philipp Volkmann, born September 5, 201961, Gernsbach; o) Dr. Käti-Andrea Koch, born on September 12, 201967, Stutensee; p) Dr. Bernhard Walter Miller, born April 19, 201965, Karlsruhe; The object of the contract is the obligation to transfer and transfer shares in various companies to the company in the context of a capital increase in kind against (i) the issue of a total of up to 2,309,016 new vin No-par value shares of the Company with a share of the share capital of EUR 1 attributable to each no-par value share at the total issue amount of up to EUR 2,309,016 and (ii) the granting of loan receivables to the contributors. The Company's Annual General Meeting approved the contract by resolution of November 28, 2013. By resolution of the same day, the Annual General Meeting of the Company decided to increase the share capital of the company by up to EUR 2,309,016 against contributions in kind with a subscription period until April 1, 2014. The capital increase will be effected by issuing up to 2,309,016 new registered registered shares with a calculated share of the share capital of EUR 1 each at the issue of EUR 1 per share (total issue amount up to EUR 2,309,016). In addition, the investors are granted loan claims against the company in return for the company.
This filing was translated from German to English. The filing refers to a past date, and does not necessarily reflect the current state. The current state is available on the following page: Augenklinik Dardenne SE, Heidelberg, Germany.
The visualizations for "Augenklinik Dardenne SE - Company statute"
are provided by
North Data
and may be reused under the terms of the
Creative Commons CC-BY license.
